192 related articles for article (PubMed ID: 21982075)
1. Associations between promoter polymorphism -106A/G of interleukin-11 receptor alpha and papillary thyroid cancer in Korean population.
Eun YG; Shin IH; Kim MJ; Chung JH; Song JY; Kwon KH
Surgery; 2012 Feb; 151(2):323-9. PubMed ID: 21982075
[TBL] [Abstract][Full Text] [Related]
2. Association between interleukin 17/interleukin 17 receptor gene polymorphisms and papillary thyroid cancer in Korean population.
Lee YC; Chung JH; Kim SK; Rhee SY; Chon S; Oh SJ; Hong IK; Eun YG
Cytokine; 2015 Feb; 71(2):283-8. PubMed ID: 25484349
[TBL] [Abstract][Full Text] [Related]
3. Single nucleotide polymorphisms of the Fas gene are associated with papillary thyroid cancer.
Eun YG; Lee YC; Kim SK; Chung JH; Kwon KH; Park IS
Auris Nasus Larynx; 2015 Aug; 42(4):326-31. PubMed ID: 25824544
[TBL] [Abstract][Full Text] [Related]
4. Association between a promoter polymorphism (rs2192752, -1028A/C) of interleukin 1 receptor, type I (IL1R1) and location of papillary thyroid carcinoma in a Korean population.
Park SW; Kim MK; Kwon KH; Kim J
Int J Immunogenet; 2012 Dec; 39(6):501-7. PubMed ID: 22594576
[TBL] [Abstract][Full Text] [Related]
5. PDGFRA promoter polymorphisms are associated with the risk of papillary thyroid cancer.
Kim MJ; Kim SK; Park HJ; Chung DH; Park HK; Lee JS; Kwon KH; Chung JH
Mol Med Rep; 2012 May; 5(5):1267-70. PubMed ID: 22327316
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 22 polymorphisms and papillary thyroid cancer.
Eun YG; Shin IH; Lee YC; Shin SY; Kim SK; Chung JH; Kwon KH
J Endocrinol Invest; 2013 Sep; 36(8):584-7. PubMed ID: 23448944
[TBL] [Abstract][Full Text] [Related]
7. Association study of integrins beta 1 and beta 2 gene polymorphism and papillary thyroid cancer.
Eun YG; Kim SK; Chung JH; Kwon KH
Am J Surg; 2013 Jun; 205(6):631-5. PubMed ID: 23388428
[TBL] [Abstract][Full Text] [Related]
8. Association study of chemokine (C-C motif) ligand 5 gene polymorphism and papillary thyroid cancer.
Kwon KH; Lee YC; Chung JH; Eun YG
J Invest Surg; 2013 Dec; 26(6):319-24. PubMed ID: 23957698
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 beta polymorphisms are associated with lymph node metastasis in Korean patients with papillary thyroid carcinoma.
Ban JY; Kim MK; Park SW; Kwon KH
Immunol Invest; 2012; 41(8):888-905. PubMed ID: 23215728
[TBL] [Abstract][Full Text] [Related]
10. A Fas-associated via death domain promoter polymorphism (rs10898853, -16C/T) as a risk factor for papillary thyroid cancer.
Eun YG; Chung DH; Kim SW; Lee YC; Kim SK; Kwon KH
Eur Surg Res; 2014; 52(1-2):1-7. PubMed ID: 24434721
[TBL] [Abstract][Full Text] [Related]
11. Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer.
Yuan Q; Bu Q; Li G; Zhang J; Cui T; Zhu R; Mu D
Clin Endocrinol (Oxf); 2016 Apr; 84(4):564-70. PubMed ID: 26052935
[TBL] [Abstract][Full Text] [Related]
12. Missense polymorphisms in XIAP-associated factor-1 (XAF1) and risk of papillary thyroid cancer: correlation with clinicopathological features.
Kim SK; Park HJ; Seok H; Jeon HS; Kim JW; Chung JH; Kwon KH; Woo SH; Lee BW; Baik HH
Anticancer Res; 2013 May; 33(5):2205-10. PubMed ID: 23645777
[TBL] [Abstract][Full Text] [Related]
13. The endothelin 1 and endothelin receptor A gene polymorphisms increase the risk of developing papillary thyroid cancer.
Aydin AF; Vural P; Doğru-Abbasoğlu S; Çil E
Mol Biol Rep; 2019 Feb; 46(1):199-205. PubMed ID: 30411193
[TBL] [Abstract][Full Text] [Related]
14. A genetic association analysis of polymorphisms, rs2282695 and rs12373539, in the FOSB gene and papillary thyroid cancer.
Han SA; Song JY; Min SY; Park WS; Kim MJ; Chung JH; Kwon KH
Exp Ther Med; 2012 Sep; 4(3):519-523. PubMed ID: 23181129
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism of IGF1R is associated with papillary thyroid carcinoma in a Korean population.
Cho SH; Kim SK; Kwon E; Park HJ; Kwon KH; Chung JH
J Interferon Cytokine Res; 2012 Sep; 32(9):401-6. PubMed ID: 22909219
[TBL] [Abstract][Full Text] [Related]
16. Association of Toll-like receptor 2 polymorphisms with papillary thyroid cancer and clinicopathologic features in a Korean population.
Kim MK; Park SW; Kim SK; Park HJ; Eun YG; Kwon KH; Kim J
J Korean Med Sci; 2012 Nov; 27(11):1333-8. PubMed ID: 23166414
[TBL] [Abstract][Full Text] [Related]
17. The effect of CASP3 rs4647610 and rs4647602 polymorphisms on tumour size and cancer stage in papillary thyroid carcinoma.
Heidari Z; Eskandari M; Aryan A; Rostamzad F; Salimi S
Br J Biomed Sci; 2020 Jul; 77(3):129-134. PubMed ID: 32151194
[TBL] [Abstract][Full Text] [Related]
18. Association of the oncostatin m receptor gene polymorphisms with papillary thyroid cancer in the korean population.
Hong IK; Eun YG; Chung DH; Kwon KH; Kim DY
Clin Exp Otorhinolaryngol; 2011 Dec; 4(4):193-8. PubMed ID: 22232715
[TBL] [Abstract][Full Text] [Related]
19. Single nucleotide polymorphisms of ataxia telangiectasia mutated and the risk of papillary thyroid carcinoma.
Song CM; Kwon TK; Park BL; Ji YB; Tae K
Environ Mol Mutagen; 2015 Jan; 56(1):70-6. PubMed ID: 25196645
[TBL] [Abstract][Full Text] [Related]
20. Association of the ATM gene polymorphisms with papillary thyroid cancer.
Gu Y; Yu Y; Ai L; Shi J; Liu X; Sun H; Liu Y
Endocrine; 2014 Apr; 45(3):454-61. PubMed ID: 23925578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]